The company has named a board of directors, filed its Form 10 statement to publicly traded securities and set its investor day for Dec. 8. GE hopes the spinoff will increase shareholder value and innovation, according to an Oct. 25 GE news release provided to Becker’s.
GE saw a 4 percent year-over-year growth in orders in the third quarter.
“Our planned spins are on track — with GE HealthCare ready to launch in January, and GE Vernova in early 2024,” GE Chair and CEO Larry Culp said. “GE HealthCare’s in the home stretch now. I’m particularly proud of what they’ve accomplished … navigating COVID, bringing in a new CEO and CFO, and now preparing to operate as an independent global leader in precision health.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.